Sun Pharma, SPARC sign licence agreement for sale of seizure drug for injection in US \
2 min read
\
\

Sun Pharma, SPARC sign licence agreement for sale of seizure drug for injection in US

09-Nov-2022
SPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for this product for the treatment of seizures in newborns in February 2022, according to Sun Pharma statement shared with stock exchanges.
09-Nov-2022 Business
\
Glenmark Pharma Q4 net profit falls 26 per cent to Rs 173 crore \
2 min read
\
\

Glenmark Pharma Q4 net profit falls 26 per cent to Rs 173 crore

28-May-2022
Mumbai (Maharashtra) [India], May 28 (ANI): Glenmark Pharmaceuticals Limited on Saturday reported a net consolidated profit of Rs 172.6 crore for the quarter ended March 2022 as compared to Rs 234 crore recorded in the corresponding period of the last year, registering a decline of 26 per cent.
28-May-2022 Business
\
Filling primary, preventive, and predictive care delivery gaps in India by reimagined ‘phygital’ health ecosystem \
6 min read
\
\

Filling primary, preventive, and predictive care delivery gaps in India by reimagined ‘phygital’ health ecosystem

20-May-2022
New Delhi [India], May 20 (ANI/PNN): India has made reasonable progress in improving access to last-mile healthcare over the last decade.
20-May-2022 Business
\
US FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk \
3 min read
\
\

US FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk

06-May-2022
Washington [US], May 6 (ANI): The US Food and Drug Administration (FDA) on Thursday said that the Johnson & Johnson vaccine that has been administered to more than 18 million Americans can potentially cause "life-threatening blood clots", and thereby warranted "limiting the authorized use of the vaccine."
06-May-2022 World
\
US FDA approves emergency use of first COVID-19 test that uses breath samples \
3 min read
\
\

US FDA approves emergency use of first COVID-19 test that uses breath samples

15-Apr-2022
A COVID-19 diagnostic test has come to light that uses breath samples to generate a positive or negative result. It has received emergency use authorization from the US Food and Drug Administration (FDA). Dubbed ‘InspectIR’, this breath analyzer COVID-19 test detects chemical components linked to coronavirus in breath samples. “Today’s authorization is yet another example […]
15-Apr-2022 World
\
US FDA clinical study proves non-contact thermometers fail to meet accuracy specifications \
3 min read
\
\

US FDA clinical study proves non-contact thermometers fail to meet accuracy specifications

15-Feb-2022
Watertown (Massachusetts) [US], February 15 (ANI/BusinessWire India): Since the start of the pandemic, non-contact infrared thermometers (NCITs) have been widely used as a screening method for fever detection in healthcare and public settings, as fever is a leading sign of COVID-19. Now, a new FDA published study demonstrates their failure to reliably detect fevers when used on adults in accordance with the NCIT instructions and fail to be within the accuracy specifications as advertised in manufacturers' literature, instructions for use, and other labeling.
15-Feb-2022 Business
\
US FDA grants the coveted Breakthrough Designation for early-stage prostate cancer detection blood test developed in India by Datar Cancer Genetics \
5 min read
\
\

US FDA grants the coveted Breakthrough Designation for early-stage prostate cancer detection blood test developed in India by Datar Cancer Genetics

15-Feb-2022
Mumbai (Maharashtra) [India], February 15 (ANI/PR Newswire): Datar Cancer Genetics today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation' for its blood test to detect early-stage prostate cancer. This is the second test from the Company that has received the Breakthrough Device Designation from the US FDA. Late last year, the company's breast cancer detection test became the first such test to receive the designation.
15-Feb-2022 Business
\
US FDA grants breakthrough designation for early-stage breast cancer detection blood test developed in India by Datar Cancer Genetics \
3 min read
\
\

US FDA grants breakthrough designation for early-stage breast cancer detection blood test developed in India by Datar Cancer Genetics

20-Nov-2021
Mumbai (Maharashtra) [India], November 20 (ANI/PRNewswire): Datar Cancer Genetics, a leading cancer research company today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation' for its blood test to detect early-stage Breast Cancer.
20-Nov-2021 Business
\
MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study \
3 min read
\
\

MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study

23-Sep-2021
Geneva [Switzerland], September 23 (ANI/PRNewswire): MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD).
23-Sep-2021 Business
\
Pfizer and BioNTech announce submission of Initial data to US FDA to support COVID-19 booster dose \
4 min read
\
\

Pfizer and BioNTech announce submission of Initial data to US FDA to support COVID-19 booster dose

17-Aug-2021
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
17-Aug-2021 World
\